Sponsor Dossier
Mundipharma
Sponsor Dossier for Mundipharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ARX-Oxycodone/Naloxone
- Brand: BI ELIGARD CP
- Brand: BUPREDERMAL
- Brand: COSOPT
- Brand: DILAUDID
- Brand: DILAUDID-HP
- Brand: ELIGARD
- Brand: FLUTIFORM
- Device (sponsor): First aid kit, non-medicated, single-use
- Device (sponsor): Dressing, hydrogel
About
Mundipharma is an Australian Private Company with ABN 87081322509, registered in NSW and currently active.
Portfolio
Mundipharma maintains 22 brands on the ARTG, of which 20 are indexable. Twenty brands have Product Information on file, 11 are PBS-listed, 10 have PBAC outcomes on record, and 5 have AusPARs on record.
Therapeutic focus
The portfolio is distributed across the following therapeutic areas: — Oncology: 11 brands — Ophthalmology: 4 brands — Pain & Anaesthesia: 3 brands — Neurology: 1 brand — Respiratory: 1 brand — Pain Management: 1 brand — Cardiology: 1 brand
PBS footprint
Mundipharma has 11 brands with at least one PBS-listed item, with the portfolio last touching the PBS schedule on 1 May 2026.
Regulatory activity
The most recent PBAC outcome for the portfolio was recorded on 1 November 2024, with 10 brands holding PBAC outcomes on record. The most recent AusPAR was issued on 6 July 2022, with 5 brands holding AusPARs on record.